- Home
- JSPR vs VCIG Comparison
JSPR vs VCIG Comparison
Compare JSPR & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JSPR | VCIG |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | Malaysia |
| Employees | 22 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9M | 14.2M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | JSPR | VCIG |
|---|---|---|
| Price | $0.69 | $0.50 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 759.6K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.81 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.32 | $0.20 |
| 52 Week High | $3.25 | $23.40 |
Technical Indicators
Market Signals| Indicator | JSPR | VCIG |
|---|---|---|
| Relative Strength Index (RSI) | 54.24 | 27.44 |
| Support Level | $0.62 | $0.20 |
| Resistance Level | $1.05 | $1.22 |
| Average True Range (ATR) | 0.13 | 0.26 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 43.37 | 0.05 |
Price Performance
Historical ComparisonAbout JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.